NCT00508313

Brief Summary

The goal of this clinical research study is to evaluate whether thermal imaging (recording body temperature) can be used to check the body's response to cancer therapy. Primary Objective:

  • The primary objective of this study is to establish techniques and methodologies of quantifying thermal signatures and their changes for cancer patients undergoing chemoradiation therapy. Secondary Objective:
  • The secondary objective is to evaluate correspondence between changes of thermal signature of a normal organ, e.g. lung or esophagus, versus the toxicity of that organ from chemoradiation therapy.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2007

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

July 26, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 27, 2007

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
Last Updated

April 8, 2016

Status Verified

September 1, 2009

Enrollment Period

1.6 years

First QC Date

July 26, 2007

Last Update Submit

April 6, 2016

Conditions

Keywords

Lung CancerHealthy ControlThermal ImagingThermal SignaturesRadiation TherapyChemoradiation Therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Participant Thermal Signature as determined by Thermal imaging (recording body temperature)

    Body temperature at the time of the thermal imaging taken using a commercial infrared camera; thermal imaging sessions several times before the cancer treatment starts, during and after the radiotherapy courses. Using thermal images taken from multiple sessions, both the absolute and relative changes of the temperature distribution will be calculated and analyzed. The location of the regions will be guided by the diagnostic computed tomography (CT) and Positron Emission Positron emission tomography (PET)/CT images for temperatures at multiple angles of body, site of radiation for skin reaction, primary cancer site and critical normal organs.

    Imaging session takes about 10 minutes to complete each time, imaging beginning at baseline and continuing till 12 months post therapy, up to 24 months

Secondary Outcomes (1)

  • Number Toxicities Experienced by Participants according to CTCAE v. 3.0

    Baseline to 24 months

Study Arms (2)

With Lung Cancer

Patients with lung cancer.

Procedure: Thermal Imaging

Healthy Participants

Healthy participants without cancer.

Procedure: Thermal Imaging

Interventions

Thermal imaging sessions, each taking approximately 10 minutes.

Healthy ParticipantsWith Lung Cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with lung cancer and healthy participants without cancer.

You may qualify if:

  • Patients with lung cancers of any stages.
  • Patients will undergo chemotherapy or radiation therapy.
  • Patients with KPS \> 70, are physically mobile and independent, and are able to stand still straight for more than 10 minutes for imaging purposes.
  • Age \>18 years

You may not qualify if:

  • Patients who had lung surgery within past 3 months.
  • Patients with breast implant or cardiac implant (pace maker or defibrillator).
  • Patients who had skin diseases (e.g. skin desquamation, dermatitis) or other medical conditions that may interfere with thermal measurement.
  • Pregnant woman
  • Extreme obese patients with body mass index \>=35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U.T.M.D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Zhongxing Liao, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2007

First Posted

July 27, 2007

Study Start

July 1, 2007

Primary Completion

February 1, 2009

Study Completion

February 1, 2009

Last Updated

April 8, 2016

Record last verified: 2009-09

Locations